Literature DB >> 20182846

Prospective comparative study of negative oral contrast agents for magnetic resonance cholangiopancreatography.

Satoru Morita1, Eiko Ueno, Ai Masukawa, Kazufumi Suzuki, Mikihiko Fujimura, Nozomi Hirabayashi, Shinya Kojima, Masami Hirata, Kazuhiro Kitajima, Yasushi Kaji.   

Abstract

PURPOSE: The aim of this study was to compare prospectively the image quality of magnetic resonance cholangiopancreatography (MRCP) using manganese chloride tetrahydrate (Bothdel Oral Solution 10) (MCT), a new negative oral contrast agent; ferric ammonium citrate (FerriSeltz powder 20%) (FAC); and no agent.
MATERIALS AND METHODS: MRCP images (TE 970 ms) of patients administered MCT (n = 19) or FAC (n = 20) at random, and 18 patients without an agent were evaluated. The subjective image quality of the overall, extrahepatic bile duct, and pancreatic duct and the degree of elimination of gastrointestinal fluid scored by two radiologists blinded to information regarding the agent were compared using Mann-Whitney's U-test.
RESULTS: The degrees of elimination of gastroduodenal fluid of MCT and FAC were significantly better than those without an agent (P < 0.01 and P < 0.01). The subjective image quality of MCT of the overall and extrahepatic bile duct were significantly better, although no significant differences for FAC were observed compared with those without an agent (P < 0.01 and P = 0.21, P = 0.02 and P = 0.16). There were no significant differences for the pancreatic duct (P = 0.12 and P = 0.19), nor were there any significant differences in the evaluations between MCT and FAC (P = 0.19-0.98).
CONCLUSION: MCT has shown performance comparable to that of conventional FAC in terms of pancreatic and biliary depiction and safety.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20182846     DOI: 10.1007/s11604-009-0395-3

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  13 in total

1.  [Value of negative oral contrast media in MR cholangiopancreatography (MRCP)].

Authors:  J Petersein; W Reisinger; S Mutze; B Hamm
Journal:  Rofo       Date:  2000-01

2.  Prospective assessment of magnetic resonance cholangiopancreatography for noninvasive imaging of the biliary tree.

Authors:  Andrew C F Taylor; Andrew F Little; Oliver F Hennessy; Simon W Banting; Peter J Smith; Paul V Desmond
Journal:  Gastrointest Endosc       Date:  2002-01       Impact factor: 9.427

3.  [Elimination of bowel fluid artifact on abdominal DWI using oral contrast agent ferric ammonium citrate].

Authors:  Toshiyuki Takahashi; Kyoichi Kato; Takeshi Nishizawa; Yasuo Nakazawa
Journal:  Nihon Hoshasen Gijutsu Gakkai Zasshi       Date:  2008-05-20

Review 4.  [Clinical efficacy of suppression and visualization of the duodenal fluid in MR cholangiopancreatography using ferric ammonium citrate].

Authors:  T Takahara; Y Kurihara; M Takahashi; Y Nakajima; T Ishikawa
Journal:  Nihon Rinsho       Date:  1998-11

5.  Large scale clinical evaluation of bowel contrast agent containing ferric ammonium citrate in MRI.

Authors:  S Hirohashi; H Uchida; K Yoshikawa; N Fujita; K Ohtomo; Y Yuasa; Y Kawamura; O Matsui
Journal:  Magn Reson Imaging       Date:  1994       Impact factor: 2.546

6.  [The optimization of MR cholangiopancreatography].

Authors:  S Obenauer; U Fischer; M Heuser; R Wilke; E Grabbe
Journal:  Rofo       Date:  1999-12

7.  Pineapple juice as a negative oral contrast agent in magnetic resonance cholangiopancreatography: a preliminary evaluation.

Authors:  R D Riordan; M Khonsari; J Jeffries; G F Maskell; P G Cook
Journal:  Br J Radiol       Date:  2004-12       Impact factor: 3.039

Review 8.  Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging.

Authors:  Y X Wang; S M Hussain; G P Krestin
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

9.  [The use of high concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent: application in MR cholangiography].

Authors:  T Takahara; M Saeki; S Nosaka; K Shimoyamada; I Suemitsu; Y Nakajima; T Yoshikawa; T Ishikawa
Journal:  Nihon Igaku Hoshasen Gakkai Zasshi       Date:  1995-08

10.  Blueberry juice: preliminary evaluation as an oral contrast agent in gastrointestinal MR imaging.

Authors:  K Hiraishi; I Narabayashi; O Fujita; K Yamamoto; A Sagami; Y Hisada; Y Saika; I Adachi; H Hasegawa
Journal:  Radiology       Date:  1995-01       Impact factor: 11.105

View more
  4 in total

1.  MR signal changes on hepatobiliary imaging after oral ingestion of manganese chloride tetrahydrate: preliminary examination.

Authors:  Nagaaki Marugami; Megumi Takewa; Yoshinori Iwaki; Yutaka Hazeyama; Kazumi Iwato; Junko Takahama; Aki Marugami; Tomoyuki Okuaki; Kimihiko Kichikawa
Journal:  Jpn J Radiol       Date:  2013-09-26       Impact factor: 2.374

2.  Prediction of pancreatic anastomotic failure after pancreatic head resection using preoperative diffusion-weighted MR imaging.

Authors:  Noriyuki Miyamoto; Satoshi Yabusaki; Keita Sakamoto; Yasuka Kikuchi; Rie Mimura; Fumi Kato; Noriko Oyama-Manabe; Bunya Takahashi; Takeshi Soyama; Daisuke Abo; Yusuke Sakuhara; Kohsuke Kudo; Hiroki Shirato; Toru Nakamura; Takahiro Tsuchikawa; Keisuke Okamura; Satoshi Hirano
Journal:  Jpn J Radiol       Date:  2014-12-11       Impact factor: 2.374

3.  Efficacy of oral contrast agents for upper gastrointestinal signal suppression in MRCP: A systematic review of the literature.

Authors:  Anne Frisch; Thula C Walter; Bernd Hamm; Timm Denecke
Journal:  Acta Radiol Open       Date:  2017-08-30

4.  Performance survey on a new standardized formula for oral signal suppression in MRCP.

Authors:  Anne Frisch; Thula C Walter; Christian Grieser; Dominik Geisel; Bernd Hamm; Timm Denecke
Journal:  Eur J Radiol Open       Date:  2017-12-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.